Concerted examination of multiple collections of single cell RNA-Seq (scRNA-Seq) data promises further biological insights that cannot be uncovered with individual datasets. However, such integrative analyses are challenging and require sophisticated methodologies. To enable effective interrogation of multiple scRNA-Seq datasets, we have developed a novel algorithm, named scMerge, that removes unwanted variation by combining stably expressed genes and utilizing pseudo-replicates across datasets. Analysis of large collections of publicly available datasets demonstrates that scMerge performs well in multiple scenarios and enhances biological discovery, including inferring cell developmental trajectories.
Introduction
Single-cell transcriptome profiling by next generation sequencing (scRNA-Seq) has enabled unprecedented resolution in studying cell identity, heterogeneity, and differentiation trajectories in various biological systems 1 . Comprehensive characterisation of large collections of scRNA-Seq datasets can provide a more holistic understanding of the underlying biological processes. However, the integration of multiple scRNA-Seq datasets remains a challenge due to prevailing technical effects associated with experiments performed across multiple conditions, experiments, and organisms. Here, we have developed scMerge, an algorithm for integrative biological analysis using multiple scRNA-Seq datasets. scMerge corrects for specific batch effects within an experiment as well as removing dataset-specific effects across collections of datasets.
While normalization methods such as SCnorm 2 , scran 3 , mnnCorrect 4 , and ComBat 5 can be applied for combining multiple scRNA-Seq datasets, they are either not specifically designed for adjusting batch effects, or are primarily designed in the context of removing batch effects within a single experiment. Alternatively, data integration methods such as Seurat 6 , fastMNN 4 , and ZINB-WaVE 7 generate dimension reduced datasets where individual genes cannot be examined for downstream analysis such as differential expression based marker identification or pseudotime trajectory estimation. Moreover, with the exception of mnnCorrect 4 , these existing methods make an underlying assumption that the batches or datasets to be integrated contain the same or similar proportions of particular cell types. This assumption can lead to incorrectly normalized data, especially when particular batches or datasets have markedly different relative proportions of cell types, e.g. integrating two datasets where one dataset contains fluorescence activated cell sorted cells and the other does not. mnnCorrect aims to address this by estimating a set of 'mutual nearest neighbors', a mapping of distinct individual cells between batches or datasets, but can be unstable due to the selection of these individual pairs of cells, as opposed to selection of pairs of cell clusters.
Methods
To enable effective integration of multiple scRNA-Seq datasets, we have developed a novel algorithm called scMerge. The scMerge algorithm consists of three key components ( Fig. 1a ):
(i) the identification of stably expressed genes (scSEGs) via a Gamma-Gaussian mixture model 8 for use as 'negative controls' for estimating unwanted factors;
(ii) the construction of pseudo-replicates to estimate the effects of unwanted factors; and (iii) the adjustment of the datasets with unwanted variation using a fastRUVIII model.
Details of these components can be found in the Online Methods. scMerge takes gene expression
matrices from a collection of datasets and a list of negative control genes whose expressions are expected to be constant across these datasets. The final output is a single normalized and batch corrected gene expression matrix with all input matrices merged ready for further downstream analysis. scMerge is available online as an R package at github.com/SydneyBioX/scMerge.
Evaluation
To assess the performance of scMerge for integrating multiple scRNA-Seq datasets, we collated fourteen publicly available scRNA-Seq datasets into six distinct data collections ( Fig. 1b , Supplementary Table 1 ). Each data collection varies across key characteristics, including number of datasets, sequencing platforms, species, as well as cell type compositions ( Fig. 1b ). We compared scMerge to other approaches, including scran 3 , mnnCorrect 4 , ComBat 5 , Seurat 6 and ZINB-WaVE 7 .
The performance of each method was evaluated using multiple criteria including visual inspection of diagnostic plots, Silhouette coefficients, adjusted Rand indices (ARI), as well as downstream biological impact ( Fig. 1c and Online Methods).
Using a mixture modelling approach 8 , our algorithm defines stably expressed genes (1076 for human and 826 for mouse) that are characterized by low variability and wide range of expression ( Fig. 2a ).
Expression of scSEGs show minimal association with cell types and developmental stages compared
to previously identified housekeeping genes from bulk transcriptome data (bHK) 9,10 or random subsets of genes (n = 1076; Fig. 2b ). We found that, in cases where batch labels are unknown and thus pseudo-replicates cannot be identified, using scSEGs as negative control genes results in better integration of data ( Fig. 2c , Supplementary Fig. 10 ), compared to bHK genes. Consistent with this, we found that using scSEGs as negative controls also results in better integration of data (F1-scores) than using ERCC spike-ins controls ( Supplementary Fig. 11 ), potentially due to the exogenous nature of ERCC probes. Conceptually, the choice of scSEGs will have a greater effect when integrating heterogeneous datasets with large differences between cells and a high proportion of highly variable genes, and as a result, appropriate selection of negative control genes has a large influence on the normalization results.
We compared scMerge with four popular and recent batch correction methods: ComBat 5 , mnnCorrect 4 , Seurat 6 and ZINB-WaVE 7 (Online Methods and Fig. 1c ) using our six scRNA-seq data collections that cover different tissues, species and protocols ( Fig. 1b ). We found that scMerge effectively removed batch and dataset specific effects across a wide range of biological systems, including a collection of human pancreatic scRNA-Seq datasets (Fig. 1b ). Visual inspection of tSNE plots (Fig. 2d ), and similarly for PCA plots ( Supplementary Fig. 1 ), shows that unlike other methods, scMerge clearly separates acinar and ductal cells. Additionally, in scMerge processed datasets, cell type information explained a higher percentage of 'wanted' variation than 'unwanted' variation 11 ( Supplementary Fig. 13 ).
In general, we found that scMerge performed favourably in terms of maintaining strong biological signal and reducing unwanted variation such as batch or data specific noise ( Fig. 3a , Supplementary   Fig. 1-8 , and Supplementary Fig. 14) . Our evaluation metrics (Online Methods) capture the trade-off between these two broad objectives. scMerge manages the trade-off between separating cell types and merging batches well ( Fig. 3a ) across multiple data collections in comparison with other methods. Summarizing these two quantities into a single F1-score (Online Methods), we found that scMerge maintains this better performance, despite choice of Silhouette coefficient or ARI as the comparison metric ( Supplementary Fig. 9 , Supplementary Table 2 ).
To illustrate the capability of scMerge to enable further downstream analyses, we studied the integrated expression matrices of the Liver data collection: four liver scRNA-seq datasets taken from different experimental settings ( Fig. 1b ). To examine stability in the face of incomplete data, we reconstructed the cell trajectories, using Monocle 2 12 , of hepatoblasts, hepatocytes, and cholangiocytes for both the full Liver data collection and for a subset of the original Liver data collection, where cells corresponding to the E17.5 time point of GSE90047 13 were removed. We found that the trajectory associated with scMerge is most consistent with the full Liver data collection ( Fig. 3b ) and agrees with current literature 14 ( Supplementary Fig. 15 ), while other methods tended to generate extraneous branches with the subset of the Liver data collection.
Finally, we illustrated the potential of scMerge in facilitating fine-grained annotation of cell types during early human and mouse development by integrating the Embryogenesis data collection: seven datasets that profiled human [15] [16] [17] and mouse 18-20 embryogenesis at various stages ranging from zygotes to late blastocysts (Fig. 1b) . By matching the zygote, 2-cell, 4-cell, 8-cell, and 16-cell stages across these datasets with semi-supervised scMerge (Online Methods), we observed clear timecourse separation of cells from zygotes to late blastocysts (Fig. 3c) , as well as clear overlap of many cells from human and mouse blastocysts, inner cell mass (ICM) regions, and human embryonic day 5 (E5). Because these three categories each contain multiple cell types, similar in their development and lineage specification stages, scMerge processed data therefore allows different cell types in these categories to be matched across species based on their relationship in the dimension reduced space.
In conclusion, scRNA-Seq technology permits a cell-type specific characterization of gene expression, enriching our understanding of the underlying biological processes. Examination of effectively integrated collections of scRNA-Seq datasets promises further biological insights that may not be possible from analyzing each individual dataset. Here we have shown that scMerge allows investigators to achieve this goal and has a significant downstream impact on the inference of cell trajectories. Integration of large collections of embryogenesis datasets across human and mouse illustrate the utility of scMerge in annotating cell types in development across different species.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. The scMerge R package is available at github.com/SydneyBioX/scMerge.
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